Lumenis is a global leader in minimally-invasive clinical solutions for the aesthetic, surgical, and ophthalmology markets, specializing in innovative energy-based technologies including laser, intense pulsed light (IPL), and radio-frequency (RF) devices. For over 50 years, Lumenis' groundbreaking products have redefined medical treatments and set numerous technological and clinical gold standards, creating solutions for previously untreatable conditions and revolutionizing existing treatment methods.

Headquartered in Israel with offices on four continents, Lumenis has a solid global footprint with nearly 1,500 professionals worldwide and sales in over 100 countries. Lumenis Vision is renowned for technological breakthroughs in ophthalmic lasers, including pioneering the first argon laser photocoagulator for ophthalmology and introducing the breakthrough OptiLight IPL treatment for dry eye management.